Document
IPR2021-00406, No. 1112-204 Exhibit - Reply Declaration of Sylvia Hall Ellis PhD (P.T.A.B. Feb. 10, 2022)
Cite Document
IPR2021-00406, No. 1112-204 Exhibit - Reply Declaration of Sylvia Hall Ellis PhD (P.T.A.B. Feb. 10, 2022)
+ More Snippets
Document
IPR2021-00406, No. 1087-180 Exhibit - Butler Affidavit (P.T.A.B. Feb. 10, 2022)
Cite Document
IPR2021-00406, No. 1087-180 Exhibit - Butler Affidavit (P.T.A.B. Feb. 10, 2022)
+ More Snippets
Document
IPR2021-00406, No. 1122-214 Exhibit - Ghofrani 2005 Search Results (P.T.A.B. Feb. 10, 2022)
Cite Document
IPR2021-00406, No. 1122-214 Exhibit - Ghofrani 2005 Search Results (P.T.A.B. Feb. 10, 2022)
+ More Snippets
Document
IPR2021-00406, No. 2052-167 Exhibit - Ex 2052 Second Declaration of Dr Aaron Waxman (P.T.A.B. Nov. 10, 2021)
Cite Document
IPR2021-00406, No. 2052-167 Exhibit - Ex 2052 Second Declaration of Dr Aaron Waxman (P.T.A.B. Nov. 10, 2021)
+ More Snippets
Document
TYVASO DPI, 214324, Review Administrative and Correspondence Documents (Orange Book May. 23, 2022)
Cite Document
TYVASO DPI, 214324, Review Administrative and Correspondence Documents (Orange Book May. 23, 2022)
+ More Snippets
Document
TYVASO DPI, 214324, Review Non-Clinical Reviews (Orange Book May. 23, 2022)
Cite Document
TYVASO DPI, 214324, Review Non-Clinical Reviews (Orange Book May. 23, 2022)
+ More Snippets
Document
TYVASO DPI, 214324, Review Product Quality Reviews (Orange Book May. 23, 2022)
Cite Document
TYVASO DPI, 214324, Review Product Quality Reviews (Orange Book May. 23, 2022)
+ More Snippets
Document
TYVASO DPI, 214324, Review Cross Discipline Team Leader Review (Orange Book May. 23, 2022)
Cite Document
TYVASO DPI, 214324, Review Cross Discipline Team Leader Review (Orange Book May. 23, 2022)
+ More Snippets
Document
TYVASO DPI, 214324, Review OfficerEmployee List (Orange Book May. 23, 2022)
Cite Document
TYVASO DPI, 214324, Review OfficerEmployee List (Orange Book May. 23, 2022)
+ More Snippets
Document
TYVASO DPI, 214324, Review Clinical Pharmacology and Biopharmaceutics Reviews (Orange Book May. 23, 2022)
Cite Document
TYVASO DPI, 214324, Review Clinical Pharmacology and Biopharmaceutics Reviews (Orange Book May. 23, 2022)
+ More Snippets
Document
TYVASO DPI, 214324, Review Other Action Letters (Orange Book May. 23, 2022)
Cite Document
TYVASO DPI, 214324, Review Other Action Letters (Orange Book May. 23, 2022)
+ More Snippets
Document
TYVASO DPI, 214324, Review Proprietary Name Reviews (Orange Book May. 23, 2022)
Cite Document
TYVASO DPI, 214324, Review Proprietary Name Reviews (Orange Book May. 23, 2022)
+ More Snippets
Document
TYVASO DPI, 214324, Review Other Reviews (Orange Book May. 23, 2022)
Cite Document
TYVASO DPI, 214324, Review Other Reviews (Orange Book May. 23, 2022)
+ More Snippets
Document
TYVASO DPI, 214324, Review Printed Labeling (Orange Book May. 23, 2022)
Cite Document
TYVASO DPI, 214324, Review Printed Labeling (Orange Book May. 23, 2022)
+ More Snippets
Document
TYVASO DPI, 214324, Review Risk Assessment and Risk Mitigation Reviews (Orange Book May. 23, 2022)
Cite Document
TYVASO DPI, 214324, Review Risk Assessment and Risk Mitigation Reviews (Orange Book May. 23, 2022)
+ More Snippets